Help us make Indico better by taking this survey! Aidez-nous à améliorer Indico en répondant à ce sondage !

26–30 Jun 2022
Riva del Garda, Italy
Europe/Rome timezone

Timepix3-based mini-tracker of charged nuclear fragments to detect anatomical changes in radiotherapy with carbon ions

27 Jun 2022, 12:30
20m
Room Garda (Riva del Garda, Italy)

Room Garda

Riva del Garda, Italy

Riva del Garda Congress Centre Loc. Parco Lido 1 I - 38066 Riva del Garda (TN)

Speaker

Dr Renato Félix Bautista (German Cancer Research Center (DKFZ))

Description

Cancer treatments have been performed with X-rays and ions (e.g., protons and carbon ions) over the years. The high dose conformity that allows better sparing of healthy tissue is a demonstrated advantage of carbon ions over x-rays [1]. This dose conformity can be impacted by to anatomical changes between treatment fractions, which can lead to an increase of the dose to healthy tissue and to a dose reduction in the tumor. Therefore, it is of great interest to monitor those anatomical changes to ensure such dose conformity. When carbon ions interact with human tissue, charged fragments are generated in nuclear interactions, which, if energetically enough, can escape the patient and provide valuable information about the ion beam during the treatment delivery [2-3]. This contribution presents a monitoring method to detect anatomical changes between treatment fractions based on charged nuclear fragment tracking.
To evaluate the performance of this treatment monitoring method, a treatment plan was delivered to a head-sized PMMA model with a typical clinical dose of 3 Gy (RBE) at the Heidelberg Ion Beam Therapy Center in Germany. Charged nuclear fragments were detected with a mini-tracker of 2 cm2 sensitive area, based on the silicon pixel Timepix3 (ADVACAM s.r.o. in Prague) detector technology developed at CERN [4]. To mimic anatomical changes inside the head model, a disk-shaped air cavity of 2 cm diameter and 0.2 cm thickness was inserted at different transverse positions (see fig.1). Moreover, three measurements for each cavity were performed: a first measurements as reference, a second measurement as fraction with no anatomical change, and a third measurement with the inserted cavity. During the data analysis, the tumor area was divided into 9 sub-regions in order to group the irradiated carbon-ion pencil beam spots (see fig.1).
By comparing the charged nuclear fragment emission profiles of the three measurements (see fig.2a), significant changes were found in the sub-regions where the air cavity was located. The detectability of the air cavity, taken as the significance of a measurement above 3𝜎, was then calculated (see fig.2b). It was found that the air cavity located closer to the mini-tracker reached a detectability of 4.8𝜎. When the cavity was located in the center position, a significance of 3.9𝜎 was obtained. A value slightly below 3𝜎 was found when the cavity was located on the far side of the mini-tracker due to the lower number of tracked fragments. Other more sophisticated data analysis strategies are being further investigated.
This contribution has quantitatively demonstrated the ability of a non-invasive monitoring method for the detection of small anatomical changes in realistic treatment deliveries, as well as its limitations. The obtained results are found to be of high clinical relevance. Therefore, this method is promising to be further investigated in clinical trials.
[1] Jäkel, Br. J. Radiol. 93 (2020) 20190428
[2] Félix-Bautista et al., Med. Phys. 48 (2021) 4411–4424
[3] Ghesquière‐Diérickx et al., Med. Phys. 49 (2022) 1776–1792
[4] Poikela et al., J. Instrum. 9 (2014) C05013–C05013

Primary author

Dr Renato Félix Bautista (German Cancer Research Center (DKFZ))

Co-authors

Pamela Ochoa Parra (German Cancer Research Center (DKFZ)) Dr Laurent Kelleter (German Cancer Research Center (DKFZ)) Gernot Echner (German Cancer Research Center (DKFZ)) Dr Marcus Winter (Heidelberg Ion-Beam Therapy Center (HIT)) Prof. Jürgen Debus (Heidelberg University Hospital,) Prof. Oliver Jäkel (German Cancer Research Center (DKFZ)) Dr Tim Gehrke (German Cancer Research Center (DKFZ)) Dr Mária Martišíková (German Cancer Research Center (DKFZ))

Presentation materials